Parathyroid hormone alone is as effective as combination in treating osteoporosisBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7417.700-a (Published 25 September 2003) Cite this as: BMJ 2003;327:700
- Scott Gottlieb
- New York
Combining parathyroid hormone with the osteoporosis drug alendronate does not seem to increase bone density any more than parathyroid hormone alone.
“It looks like you don't see the synergism or additive effect that we had hoped to see,” said Dennis Black, professor of epidemiology and biostatistics at the University of California, San Francisco, and the study's lead investigator.
The study was published in the online version of the New England Journal of Medicine ahead of schedule to coincide with presentations at a meeting of the American Society for Bone and Mineral Research and appears in the print journal on 25 September (2003;349:1019-26).
The interim results come from a one year study, sponsored …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial